Delivery Order SPE2DB22D2007-SPE2DB25FJ5GW
- Not listed
- The Defense Logistics Agency awarded a $18,237.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a delivery order valued at $77,905.19 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets. This competitively awarded, firm fixed-price delivery order is set to be completed by August 25, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating that AmerisourceBergen competed against other vendors to secure this pharmaceutical supply contract....
- The Defense Logistics Agency awarded a delivery order valued at $51,982.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,421.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $18,761.49 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 14, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count packages) with a completion date of August 29, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,929.86 for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitively awarded, firm fixed-price contract was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,533.97 for 60 tablets of Eliquis 5 mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $64,631.26 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on June 4, 2025, with an ultimate completion date of June 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5GWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $62,376.57 for 60-count tablets of Eliquis 5 mg, with an ultimate completion date of September 25, 2025. This is a firm fixed-price, non-set-aside contract performed from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical supply requirement supporting federal healthcare needs. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare systems worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The contract demonstrates AmerisourceBergen Drug Corp's established capacity to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.4k | 9/24/25 |